Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 60S large ribosomal subunit is the larger component of the eukaryotic 80S ribosome, serving as the catalytic heart of protein synthesis [7, 18]. It is composed of three ribosomal RNA (rRNA) strands (28S, 5.8S, and 5S) and approximately 47 to 49 ribosomal proteins, which together form the peptidyl transferase center (PTC) and the peptide exit tunnel [7, 14, 18, 22]. The 60S subunit is essential for translating messenger RNA into functional proteins, a process frequently hijacked or upregulated in malignant cells to support rapid proliferation [2, 19]. Therapeutically, the 60S subunit is targeted by inhibitors like omacetaxine mepesuccinate, which binds to the A-site to block translation elongation, particularly affecting short-lived oncoproteins like Bcr-Abl and Mcl-1 [1, 2, 3]. Beyond its role in translation, components of the 60S subunit participate in extra-ribosomal signaling pathways, such as the regulation of the p53 tumor suppressor via the RPL5/RPL11-MDM2 axis, making it a critical node in both cellular metabolism and oncology [8, 12, 13, 20]. Polysomes, which are clusters of multiple ribosomes translating a single mRNA strand, represent the active functional state of this target in the cytoplasm [4, 11].
Omacetaxine mepesuccinate binds specifically to the A-site cleft in the peptidyl-transferase center of the 60S ribosomal subunit, sterically hindering the positioning of aminoacyl-tRNAs and thereby preventing the initial elongation step of protein synthesis [1, 2, 3, 4].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 60S large ribosomal subunit (60S subunit).